Therapeutic agent for heart disease using map kinase tnni3k
AssigneeKumamoto University
InventorsHoichi Yorinaka, Jin-Feng Ding, Xian-Min Meng
Life of this patent
Estimating the term…
Abstract
An object to be achieved by the present invention is to provide a therapeutic means for heart disease such as myocardial ischemia or myocardial infarction. The present invention provides a therapeutic agent for heart disease which comprises a myocardial progenitor cell expressing MAP kinase TNNI3K at a high level as an active ingredient.
Claims7
A therapeutic agent for heart disease which comprises a myocardial progenitor cell expressing MAP kinase TNNI3K at a high level as an active ingredient.
A method for diagnosing heart disease which comprises measuring the expression level of MAP kinase TNNI3K in myocardial cells.
Dependencies are inferred from the claim text.